These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9186398)

  • 1. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    De Keyser J; Zwanikken C
    Lancet; 1997 Jun; 349(9066):1696; author reply 1697. PubMed ID: 9186398
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    Reinhardt C; Reul JM; Melms A
    Lancet; 1997 Jun; 349(9066):1697-8. PubMed ID: 9186401
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    Tremlett H
    Lancet; 1997 Jun; 349(9066):1696-7. PubMed ID: 9186400
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral or intravenous methylprednisolone for acute relapses of MS?
    Barkhof F; Polman C
    Lancet; 1997 Mar; 349(9056):893-4. PubMed ID: 9093245
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
    Chataway J
    Mult Scler; 2014 May; 20(6):643-5. PubMed ID: 24756993
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
    Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
    Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
    Tremlett HL; Luscombe DK; Wiles CM
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

  • 9. Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.
    Segamarchi C; Silva B; Saidon P; Garcea O; Alonso R
    Mult Scler Relat Disord; 2020 Nov; 46():102449. PubMed ID: 32853893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids in the treatment of multiple sclerosis.
    Myhr KM; Mellgren SI
    Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral rather than intravenous corticosteroids should be used to treat MS relapses - No.
    Bowen JD; Qian P
    Mult Scler; 2017 Jul; 23(8):1058-1060. PubMed ID: 28326883
    [No Abstract]   [Full Text] [Related]  

  • 12. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al].
    Hohlfeld R; Engelhardt D
    Nervenarzt; 1994 Feb; 65(2):148. PubMed ID: 8164771
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes.
    Le Page E; Edan G
    Mult Scler; 2017 Jul; 23(8):1056-1058. PubMed ID: 28326884
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.
    Grau-López L; Teniente-Serra A; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Martínez-Cáceres EM; Ramo-Tello C
    Mult Scler; 2015 Apr; 21(5):646-50. PubMed ID: 25145693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
    Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
    Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous corticosteroids in the treatment of multiple sclerosis.
    Ohno R; Hamaguchi K; Sowa K; Tanaka H; Watanabe Y
    Jpn J Med; 1987 May; 26(2):212-6. PubMed ID: 3626160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
    Pascual AM; Boscá I; Escutia M; Bernat A; Coret F; Casanova B
    Neurologia; 2008 Mar; 23(2):73-7. PubMed ID: 17641984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
    Alam SM; Kyriakides T; Lawden M; Newman PK
    J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1219-20. PubMed ID: 8229035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronotherapy using corticosteroids for multiple sclerosis relapses.
    Glass-Marmor L; Paperna T; Ben-Yosef Y; Miller A
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):886-8. PubMed ID: 17056624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.